Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database
Journal of the American Academy of Dermatology · 2024
DOI: 10.1016/j.jaad.2024.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2024. Verfasst von Rachita Pandya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, Perelman Center for…. Hauptthemen laut MEDLINE: Dermatomyositis, Disease Progression, Severity of Illness Index, Databases, Factual. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases, US Department of Veterans Affairs.
Abstract (Originalsprache)
BACKGROUND: Disease characteristics of classic dermatomyositis (DM) and clinically amyopathic DM (CADM) are well established, but there exists limited knowledge on the disease progression of these subtypes. OBJECTIVE: The objective of this study was to longitudinally track and characterize classic DM and CADM patients who experience changes in disease presentation. METHODS: We conducted a retrospective review of prospectively collected data on 269 DM patients from a longitudinal database. RESULTS: A total of 51% of the patients had classic DM and 49% had CADM. Forty percent of the classic DM patients became postmyopathic (PmDM). Median Cutaneous Dermatomyositis Disease Area and Severity Index activity (CDASI-A) score was lower in PmDM patients than in classic DM patients (13.0 vs 16.0), but 45% of the PmDM patients had CDASI-A scores > 14. Five percent of the CADM patients developed muscle involvement. Compared with CADM patients, those who developed muscle symptoms had milder skin disease before subtype conversion (median CDASI-A 12.0 vs 16.0) and at subtype conversion (median CDASI-A 9.0 vs 16.0). LIMITATIONS: This was a retrospective study conducted at a single tertiary-care dermatology clinic. CONCLUSIONS: Forty percent of the classic DM patients became PmDM. The majority continue with muscle disease, and many continue to have moderate/severe skin disease. CADM has a low risk of progressing to muscle disease, with the extent of skin disease as a potential predictive factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, Perelman Center for Advanced Medicine, Perelman School of Medicine, University of Pennsyl…
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- US Department of Veterans Affairs
- Health Services Research and Development
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- National Institutes of Health
Zitieren
APA
Pandya, R., Kleitsch, J., Lim, D., & Werth, V. P. (2024). Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.02.007
Vancouver
Pandya R, Kleitsch J, Lim D, Werth VP. Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2024.02.007
BibTeX
@article{Pandya2024,
author = {Pandya, Rachita and Kleitsch, Julianne and Lim, Darosa and Werth, Victoria P},
title = {Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
doi = {10.1016/j.jaad.2024.02.007}
}
EUVIMED